Q4 2024 Earnings Call Transcript March 12, 2025 Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.03, ...

Despite exceeding Street forecasts with its Q4 2024 financials, Amarin Corporation (NASDAQ:AMRN) traded lower in the ...

DUBLIN and BRIDGEWATER, N.J., March 12, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the fourth quarter of 2024 and provided a review of fourth ...

Amarin Corporation plc has announced a planned change in the ratio of its American Depositary Shares (ADS) beginning around April 11, 2025, adjusting from one ADS representing one ordinary share ...

Amarin Corporation reported Q4 2024 revenues of $62.3 million, with operating expenses of $43 million and significant global growth in VASCEPA. Operating expenses decreased to $43.0 million ...

Despite exceeding Street forecasts with its Q4 2024 financials, Amarin Corporation (NASDAQ:AMRN) traded lower in the premarket on Wednesday as the Irish biotech announced plans to implement a ...

Welcome to Amarin Corporation's conference call to discuss its fourth-quarter and full-year 2024 business update and financial results. I would like to turn the conference call over to Mark Marmur ...

DUBLIN and BRIDGEWATER, N.J., March 12, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the fourth quarter of 2024 and provided a review of ...

Welcome to Amarin Corporation's Conference Call to discuss its Fourth Quarter and Full Year 2024 Business Update and Financial Results. I would like to turn the conference call over to Mark Marmur ...